Status:
UNKNOWN
Neurophysiological Diagnosis for ICU Septic Shock Patients
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
ICU Acquired Weakness
Eligibility:
All Genders
18+ years
Brief Summary
Patients hospitalized in the Intensive Care Unit (ICU) are at risk for developing severe disabilities, physical or cognitive. In particular, ICU-acquired weakness is frequent. The causes of this weakn...
Eligibility Criteria
Inclusion
- • Patients admitted to the ICU with a septic shock and ventilated for more than 72 hours.
Exclusion
- Hospitalization for more than 7 days before intubation.
- Functional disability at admission of ≥4 (Requires constant nursing care and attention, bedridden, incontinent) in the Modified Rankin Scale.
- Lower limb disorders precluding nerve conduction studies (NCV) and electromyography (EMG), such as clinical edema of the lower limbs, or fractures, amputation, and plaster casts of the lower limbs.
- Evidence of altered neuromuscular transmission at repetitive stimulation test either caused by neuromuscular blocking agents or disease.
- Burn patients admitted to ICU.
- Patient requesting withdrawal of therapies.
Key Trial Info
Start Date :
January 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03802500
Start Date
January 23 2019
End Date
December 31 2019
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUV
Lausanne, Canton of Vaud, Switzerland, 1000